drugset / Trial / NCT00620256

Adjunctive Study of AL-37807 Ophthalmic Suspension

NCT00620256

Phase 2 Completed 129 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all dosed concomitantly with Xalatan, in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2007-11
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-37807 Unknown 0.1 % Other
Comparator Timolol Other / unclassified 0.5 % Other
Background Latanoprost Small molecule Other